127
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Discrepancies between creatinine‐based and cystatin C‐based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population

, , , &
Pages 344-349 | Received 11 Sep 2008, Accepted 04 Nov 2008, Published online: 08 Jul 2009

References

  • Coresh J., Selvin E., Stevens L. A., Manzi J., Kusek J. W., Eggers P., Van Lente F., Levey A. S. Prevalence of chronic kidney disease in the United States. J Am Med Assoc 2007; 298: 2038–47
  • Hallan S. I., Vikse B. E. Relationship between chronic kidney disease prevalence and end‐stage renal disease risk. Curr Opin Nephrol Hypertens 2008; 17: 286–91
  • Couchoud C., Pozet N., Labeeuw M., Pouteil‐Noble C. Screening early renal failure: cut‐off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999; 55: 1878–84
  • Perrone R. D., Madias N. E., Levey A. S. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933–53
  • Lamb E. J., O'Riordan S. E., Delaney M. P. Kidney function in older people: pathology, assessment and management. Clin Chim Acta 2003; 334: 25–40
  • Levey A. S., Coresh J., Greene T., Stevens L. A., Zhang Y. L., Hendriksen S., Kusek J. W., Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247–54
  • Delanaye P., Cavalier E., Maillard N., Krzesinski J. M., Mariat C. Creatinine calibration in NHANES: is a revised MDRD study formula needed?. Am J Kidney Dis 2008; 51: 709–10
  • Delanaye P., Cavalier E., Krzesinski J. M. Determining prevalence of chronic kidney disease using estimated glomerular filtration rate. J Am Med Assoc 2008; 299: 631
  • Froissart M., Rossert J., Jacquot C., Paillard M., Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft–Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763–73
  • Newman D. J. Cystatin C. Ann Clin Biochem 2002; 39: 89–104
  • Grubb A. O. Cystatin C‐properties and use as diagnostic marker. Adv Clin Chem 2000; 35: 63–99
  • Seronie‐Vivien S., Delanaye P., Pieroni L., Mariat C., Froissart M., Cristol J. P. Cystatin C: point d'étape et perspectives. Ann Biol Clin (Paris) 2008; 66: 301–23
  • Stevens L. A., Coresh J., Schmid C. H., Feldman H. I., Froissart M., Kusek J., Rossert J., Van Lente F., Bruce R. D., III., Zhang Y. L., Greene T., Levey A. S. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395–406
  • Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–10
  • Hallan S. I., Coresh J., Astor B. C., Asberg A., Powe N. R., Romundstad S., Hallan H. A., Lydersen S., Holmen J. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275–84
  • Hallan S., Asberg A., Lindberg M., Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004; 44: 84–93
  • Selvin E., Manzi J., Stevens L. A., Van Lente F., Lacher D. A., Levey A. S., Coresh J. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004. Am J Kidney Dis 2007; 50: 918–26
  • Macdonald J., Marcora S., Jibani M., Roberts G., Kumwenda M., Glover R., Barron J., Lemmey A. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 2006; 48: 712–19
  • Rule A. D., Gussak H. M., Pond G. R., Bergstralh E. J., Stegall M. D., Cosio F. G., Larson T. S. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004; 43: 112–19
  • Van Den Noortgate N. J., Janssens W. H., Delanghe J. R., Afschrift M. B., Lameire N. H. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc 2002; 50: 1278–82
  • Larsson A., Malm J., Grubb A., Hansson L. O. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25–30
  • Knight E. L., Verhave J. C., Spiegelman D., Hillege H. L., de Zeeuw D., Curhan G. C., de Jong P. E. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416–21
  • Wang Y., Chen X., Song Y., Caballero B., Cheskin L. J. Association between obesity and kidney disease: a systematic review and meta‐analysis. Kidney Int 2008; 73: 19–33
  • Bjarnadottir M., Grubb A., Olafsson I. Promoter‐mediated, dexamethasone‐induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617–23
  • Jayagopal V., Keevil B. G., Atkin S. L., Jennings P. E., Kilpatrick E. S. Paradoxical changes in cystatin C and serum creatinine in patients with hypo‐ and hyperthyroidism. Clin Chem 2003; 49: 680–1
  • Glassock R. J., Winearls C. An epidemic of chronic kidney disease: fact or fiction?. Nephrol Dial Transplant 2008; 23: 1117–21

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.